CClinicalTrials.gg
CompletedNCT06730984Updated Jun 5, 2026

Endoscopy-Assisted Tracheal Intubation Versus Conventional Tracheal Intubation for Endoscopic Submucosal Dissection (ESD)

An interventional study of Endoscopy-Assisted Tracheal Intubation and Traditional Tracheal Intubation in Tracheal Intubation, Endoscopic Submucosal Dissection and Endoscopy-Assisted, sponsored by Ningbo No. 1 Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Ningbo No. 1 Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study plans to enroll 132 patients undergoing upper gastrointestinal endoscopic submucosal dissection (ESD). Patients will be randomly divided into a control group (conventional tracheal intubation) and an experimental group (endoscopy-assisted tracheal intubation). Patients meeting the inclusion criteria and not falling under the exclusion criteria will be invited to participate in the study. Upon providing voluntary consent, the research physician will arrange for the patient's inclusion in the study. After signing the informed consent form, the research physician will collect the patient's basic information, medical history, and other details, followed by timing the preoperative preparation period and evaluating postoperative discomfort

02

Conditions studied

  • Tracheal Intubation
  • Endoscopic Submucosal Dissection
  • Endoscopy-Assisted
  • Video Laryngoscope
03

In context

Lead sponsor

Ningbo No. 1 Hospital is the lead sponsor of 56 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients undergoing endoscopic submucosal dissection (ESD) at Ningbo University Affiliated First Hospital from December 2024 to December 2026.
  • Aged between 18 and 75 years.
  • Patients who voluntarily agree to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Individuals under 18 years of age.
  • Patients unwilling or unable to provide informed consent.
  • Patients with severe chronic cardiac or pulmonary disease, or those who have required hospitalization for coronary or cerebrovascular events or radiotherapy within the past 3 months.
  • Patients with severe abdominal symptoms such as severe pain, bloating, or nausea.
  • Patients with inadequate preoperative preparation.
  • Individuals requiring lifelong anticoagulant therapy, those with severe bleeding disorders, or those who have recently taken anticoagulant or antiplatelet medications.
  • Pregnant or breastfeeding individuals.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
132 participants (actual)

Study arms

  • Experimental
    Endoscopy-Assisted Tracheal Intubation

    Tracheal Intubation Under Endoscopic Guidance

    Other: Endoscopy-Assisted Tracheal Intubation

  • Active comparator
    Traditional Tracheal Intubation

    Tracheal Intubation Under Video Laryngoscopy

    Other: Traditional Tracheal Intubation

Interventions

  • OtherEndoscopy-Assisted Tracheal Intubation

    Tracheal Intubation Under Endoscopic Guidance

  • OtherTraditional Tracheal Intubation

    Tracheal Intubation Under Video Laryngoscopy

06

What researchers measure

Primary outcomes

  1. preoperative preparation time

    the time from Initiate Anesthesia Induction to Insert the Therapeutic Endoscope into the Oral Cavity

    Time frame: 30 minutes

Secondary outcomes

  1. The time to view the vocal cords (TVVC)

    the time from inserting the tracheal tube into mouth to the operator view the the entire vocal cords

    Time frame: 10 minutes

  2. The time to advance the tracheal tube into trachea (TATT)

    the time from viewing the entire vocal cords to insert the tracheal tube into trachea successfully

    Time frame: 10 minutes

07

Study locations

1 site
  • the First Affiliated Hospital of Ningbo University
    Ningbo, Zhejiang 315000, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06730984
Lead sponsor
Ningbo No. 1 Hospital
Responsible party
Sponsor
First posted
Dec 12, 2024
Start date
Dec 10, 2024
Primary completion
Dec 30, 2025
Completion
Dec 30, 2025
Last update
Jun 5, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion